ArticleCancers2022

Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy.

Ekaterina Mikhailova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.